P/B
1,2
Integra LifeSciences
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
$1.2B
Market Cap • 9/14/2026
1969
(57 years)
Founded
1995
(31 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,7
P/EBITDA
5,6
P/OCF
14,3
P/FCF
47,4
P/E
—
BVPS
13,5
EPS
—
Market Cap
Market Cap
1,2B
EV
3B
EV/Revenue
1,8
EV/EBITDA
13,7
EV/EBIT
45,7
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-0,1%
Total Yield
-0,1%
Dividend Yield 5Y
0%
Payout
0%
Retained Earnings
423,3M
Profitability
Gross Margin
52,5%
EBITDA Margin
13,3%
EBIT Margin
4%
Net Margin
—
D&A/EBITDA
6,9%
R&D/Revenue
5,8%
Capex/Revenue
3,6%
Capex/D&A
38,8%
Capex/OCF
69,8%
SBC/OCF
26,3%
% PPE
16,4%
% Goodwill
17,2%
ROE
—
ROIC
88%
Growth
CAGR Revenue 5Y
1,8%
CAGR Op. Income 5Y
-19,4%
CAGR OCF 5Y
-22,8%
Leverage
N.D./EBITDA
8,1
Debt/Equity
0%
Current Ratio
3,6
Quick Ratio
1,6
Interest Coverage
71,4%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!